Kenneth E Robertson
Overview
Explore the profile of Kenneth E Robertson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
192
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ludvik B, Frias J, Tinahones F, Wainstein J, Jiang H, Robertson K, et al.
Lancet Diabetes Endocrinol
. 2018 Feb;
6(5):370-381.
PMID: 29483060
Background: Glucagon-like peptide-1 (GLP-1) receptor agonists and sodium-glucose co-transporter-2 (SGLT2) inhibitors improve glycaemic control and reduce bodyweight in patients with type 2 diabetes through different mechanisms. We assessed the safety...
2.
Gallwitz B, Dagogo-Jack S, Thieu V, Garcia-Perez L, Pavo I, Yu M, et al.
Diabetes Obes Metab
. 2017 Aug;
20(2):409-418.
PMID: 28817231
Aims: To evaluate the efficacy and safety of dulaglutide 1.5 and 0.75 mg in patients with type 2 diabetes by subgroups of gender, duration of diabetes and baseline glycated haemoglobin...
3.
Ferdinand K, White W, Calhoun D, Lonn E, Sager P, Brunelle R, et al.
Hypertension
. 2014 Jul;
64(4):731-7.
PMID: 24980665
Glucagon-like peptide-1 receptor agonists, used to treat type 2 diabetes mellitus, are associated with small reductions in systolic blood pressure (SBP) and increases in heart rate. However, findings based on...